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Small-cell neuroendocrine carcinoma of the breast
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A small-cell carcinoma is one of the histologic subtypes of primary neuroendocrine carcinomas of the breast. A small-cell car-
cinoma is a rare entity of the breast and exhibits similar morphologic features as neuroendocrine tumors of the gastro-
intestinal tract and lung. We present the imaging and pathologic findings of a primary small-cell neuroendocrine carcinoma 
of the breast. This is the first report of a primary small-cell carcinoma arising from the breast in Korea.
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INTRODUCTION
Neuroendocrine neoplasms are defined as epithelial ne-
oplasms with predominant neuroendocrine differentia-
tion, which range from non-aggressive carcinoid tumors 
to highly aggressive small cell carcinomas [1]. Neuroendo-
crine neoplasms arise in most organs of the body, espe-
cially the lungs, pancreas, and gastrointestinal tract [2]. 
Since Wade et al. [3] first reported a neuroendocrine tumor 
in 1983, several cases have been reported. We present a 
case of a primary neuroendocrine carcinoma of the breast 
with imaging and pathologic findings.
CASE REPORT
In July 2007, a 64-year-old woman sought evaluation at 
our hospital for a palpable lesion in the left breast which 
had been detected several days earlier. The medical his-
tory was significant for diabetes mellitus and hyper-
tension. A 0.8-cm irregular, hypoechoic lesion near the left 
areola was demonstrated on sonography (Fig. 1A). A biop-
sy was recommended due to the suspicious shape; how-
ever, the patient declined any procedures which would 
permit pathologic confirmation.
In December 2010, the patient visited our hospital with 
symptoms of exertional dyspnea of 1 month duration. 
Because of the underlying diabetes mellitus and hyper-
tension, the imaging work-up focused on the pulmonary 
symptoms. A chest computed tomography (CT) showed 
multiple nodular septa, fissures, and pleural thickening of 
both lungs with a large bilateral pleural effusion and mul-
tiple enlarged lymph nodes in the paratracheal and axil-
lary areas, suggestive of lymphangitic metastasis. There 
were no pulmonary nodules, mediastinal masses, or bron-
chial abnormalities. In addition to the pulmonary find-Small cell carcinoma of the breast
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Fig. 1. (A) Sonography showed small irregular hypoechoic lesion with angular margin and spiculations (arrows). (B) Mammography 
showed ill-defined hyperdense mass in left subareolar area which was adherent to areola. Nipple retraction, diffuse skin thickening, and 
multiple enlarged lymph nodes in left axilla were noted with shrinkage of volume of left breast. (C) Sonography showed irregular 
hypoechoic mass with invasion to nipple (arrows).
Fig. 2. (A) Microscopic finding showed infiltrating nests of small cells in fibrotic stroma. Tumor cells had small hyperchromatic nuclei and 
scanty cytoplasms (H&E, ×200). (B) Immunohistochemical stain showed strong positivity of tumor cells for neuron-specific enolase (×400).
ings, a large irregular mass was incidentally detected in 
the left breast with overlying skin thickening and nipple 
retraction. The breast mass was evaluated by mammog-
raphy and sonography. On mammography, an ill-defined 
hyperdense mass occupied the left subareolar area which 
was adherent to the areola (Fig. 1B). Nipple retraction, dif-
fuse skin thickening, and multiple enlarged lymph nodes 
in the left axilla were noted with shrinkage of the volume 
of the left breast. An irregular hypoechoic mass with in-
vasion to the nipple was demonstrated on sonography 
(Fig. 1C). Abdominal and pelvic CT and positron emission 
tomography-CT were obtained to check the other organs 
of the body, and showed no evidence of abdominal or pel-
vic lesions. The final diagnosis of the imaging studies was 
a primary breast tumor with pulmonary metastasis. We 
took a biopsy of the breast mass to confirm the pathology. 
Microscopic finding showed infiltrating nests of small 
cells in the fibrotic stroma, the tumor cells of which had 
small hyperchromatic nuclei and scanty cytoplasms (Fig. 
2A). Immunohistochemical stain showed strong positivity 
of the tumor cells for neuron-specific enolase, suggestive 
of small cell neuroendocrine carcinoma (Fig. 2B).
DISCUSSION
Primary neuroendocrine carcinomas of the breast ex-
hibit morphologic features similar to neuroendocrine tu-
mors of the gastrointestinal tract and lungs. Primary neu-
roendocrine carcinomas express neuroendocrine markers Jin Kyung An, et al.
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in >50% of the cell population. Neuroendocrine carcino-
mas of the breast represent 2 to 5% of breast carcinomas. In 
2003, the World Health Organization classification of tu-
mors included three histologic subtypes of neuroendo-
crine tumors: solid neuroendocrine carcinoma; small cell 
carcinoma; and large cell neuroendocrine carcinoma. A 
small cell neuroendocrine carcinoma is morphologically 
indistinguishable from its counterpart in the lung on the 
bases of histologic and immunohistochemical features [4]. 
Therefore, exclusion of an extramammary primary site 
and/or demonstration of an in situ component within the 
breast should be confirmed to diagnose the primary small 
cell neuroendocrine carcinoma of the breast [5]. Primary 
small cell neuroendocrine carcinomas of the breast as also 
known as oat cell carcinomas, high-grade neuroendocrine 
carcinomas, or small cell undifferentiated carcinomas.
The histologic characteristics of primary small cell neu-
roendocrine carcinomas are scant cytoplasm, fine gran-
ular chromatin, inconspicuous nucleoli, and a high mitotic 
rate. Necrosis is common and may be associated with oth-
er conventional breast carcinoma patterns. There is no 
consistent pattern of neuroendocrine marker expression; 
however, most tumors are reactive for neuron-specific 
enolase, cytokeratin, and one or more neruoendocrine dif-
ferentiation indicators (Grimelius stain, synaptophysin, 
Leu 7, serotonin, bombesin, and chromogranin A or B) [6]. 
Estrogen and progesterone receptors are expressed in 
>50% of small cell carcinomas [4]. The histogenesis of pri-
mary small cell neuroendocrine carcinomas is still unclear. 
It has been suggested that a small cell neuroendocrine car-
cinoma is a variant of a metaplastic carcinoma arising from 
usual lobular or ductal carcinoma [4] or multipotential 
stem cells capable of divergent differentiation [7].
Breast small cell carcinomas should be differentiated 
from small cell carcinomas from another site, lobular car-
cinomas, or lymphomas; immunohistochemistry may 
help to distinguish such lesions. Breast small cell carcino-
mas are positive for cytokeratin 7 and negative for cytoker-
atin 20, whereas pulmonary small cell carcinomas are neg-
ative for both markers [4]. E-cadherin is negative in lobu-
lar carcinomas, but 100% positive in small cell carcinomas 
[8]. Lymphomas are immunoreactive for leukocyte com-
mon antigen, CD20, or CD3. In the current case, light mi-
croscopy showed infiltrating small discohesive cells in the 
hyalinized stroma. The tumor cells had small nuclei and 
scanty cytoplasm admixed with reactive small lympho-
cytes. The tumor cells were initially thought to be lym-
phoid cells, but immunohistochemical stains revealed 
positive for epithelial membrane antigen and cytokeratin, 
but negative for leukocyte common antigen, CD3, CD20. 
The tumor cells were positive for neuron-specific enolase 
and E-cadherin. Thus, we excluded lymphomas and lobu-
lar carcinomas from the differential diagnosis. Perineural 
invasion and tumor necrosis were present. Estrogen and 
progesterone receptors were negative, Her-2 was three 
positive, and Ki-67 was elevated (70%), suggesting ag-
gressive tumor characteristics. 
The serum tumor marker CA15-3 was within normal 
limit in our case and was not helpful to differentiate the 
primary lesion. Kinoshita et al. [7] reported elevated levels 
of serum carcinoembryonic antigen and NCC-ST-439 and 
Kitakata et al. [9] reported that the levels of the serum tu-
mor markers carcinoembryonic antigen, CA15-3, NCC- 
ST-439, and squamous cell carcinoma antigen  were within 
normal limits. More data seem to be necessary to find a 
constant pattern of the serum tumor markers about the 
primary small cell carcinomas of the breast.
Small cell neuroendocrine carcinomas of the breast 
have been reported in several cases, which is not sufficient 
to characterize the imaging findings of the tumor [9,10]. 
The radiologic findings of our case were similar to ad-
vanced breast malignancy of the other histologic types. 
Although the pathologic findings were not confirmed, we 
postulated that the palpable small lesion detected in 2007 
might have been an early stage of this mass. The small le-
sion was located at the 1 o’clock direction near the left nip-
ple in 2007 and the imaging studies obtained in 2010 
showed that the mass was in the same location. In such a 
case, it is likely that it took 3 years for the early lesion to 
progress to an advanced lesion. Although the period dur-
ing which malignant lesions progress is variable and de-
pends on the histologic type, grade, and patient’s health, 
the duration of time could be a feature of progression of 
small cell neuroendocrine carcinomas of the breast. Small 
cell carcinomas have been considered as undifferentiated 
carcinomas and aggressive tumors, resulting in poor Small cell carcinoma of the breast
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prognosis. Recently, it has been reported that the prog-
nosis depends on the stage at the time of diagnosis and 
that low-stage small cell carcinomas respond to conven-
tional treatment without progression of the disease [9].
In summary, the primary small cell carcinoma of the 
breast in our patient presented with imaging findings sim-
ilar to the usual type of ductal carcinoma in early and ad-
vanced stages. Although the period of tumor progression 
depends on variable factors, our case could serve as a val-
uable example to assess the biology of this tumor. Immu-
nohistochemistry may help to differentiate this rare breast 
malignancy from the other tumors which have similar 
gross and microscopic features.
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